Sandoz Group Ag reiterated earnings guidance for the full year 2024. For the year, The company reiterates guidance expecting net sales to grow mid-single digit in constant currencies versus prior year .
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
32.34 CHF | +0.81% | +0.74% | +20.14% |
May. 22 | Sandoz: Marketing authorization for Wyost and Jubbonti in the EU | CF |
May. 22 | Sandoz Group Receives EU Approval for Cancer, Osteoporosis Biosimilars | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+20.14% | 15.08B | |
+18.71% | 44.35B | |
+19.49% | 14.37B | |
+57.58% | 13.06B | |
-0.05% | 6.79B | |
-9.70% | 6.75B | |
-8.87% | 5.73B | |
+13.66% | 5.64B | |
+4.00% | 4.66B | |
-13.26% | 4.27B |
- Stock Market
- Equities
- SDZ Stock
- News Sandoz Group AG
- Sandoz Group Ag Reiterates Earnings Guidance for the Full Year 2024